Biomedcentral.com is tracked by us since April, 2011. Over the time it has been ranked as high as 1 759 in the world, while most of its traffic comes from China, where it reached as high as 1 471 position. Molcelltherapies.biomedcentral.com receives less than 2.54% of its total traffic. It was owned by several entities, from Biomed Central Tomas Ramanauskas () to Ramanauskas Tomas of BiomedCentral, it was hosted by Fastly and Fastly Inc.. While ENOM INC. was its first registrar, now it is moved to EuroDNS S.A..

Molcelltherapies.biomedcentral has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Molcelltherapies.biomedcentral.com is poorly ‘socialized’ in respect to any social network. According to MyWot and Google safe browsing analytics, Molcelltherapies.biomedcentral.com is a fully trustworthy domain with no visitor reviews.